Clincosm LogoSign in Get a demo

Oligodendrogliomas

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Clinical Development of Cancer-Specific MRS Biomarkers in

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Clinical Development of MR Spectroscopy and Imaging in Brain

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla Scanning
  • 7 Tesla Scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Astrocytomas, Oligodendrogliomas, Oligoastrocytoma Trial in Guangzhou (Radiation therapy, Temozolomide)

Terminated
  • Astrocytomas
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Aug 4, 2014

Research of Molecular and Metabolic Markers in

Completed
  • Oligodendrogliomas
    • Strasbourg, France
      Natacha Entz-Werle
    Aug 29, 2011